L-Cystinedi-β-naphthylamide

CAS : 1259-69-4

Ref. 3D-FC66230

Informations sur le produit

• Nom: L-Cystinedi-β-naphthylamide
• Synonymes: (2R,2′R)-3,3′-Dithiobis[2-amino-N-2-naphthalenylpropanamide], (H-Cys-.beta.NA)2 (Disulfide bond), <span class="text-smallcaps">L</span>-Cystinedi-β-naphthylamide, <span class="text-smallcaps">L</span>-Cystinyl-di-β-naphthylamide, <span class="text-smallcaps">L</span>-Cystyl-di-β-naphthylamide, N,N'-dinaphthalen-2-yl-L-cystinamide, N,N'-dinaphthalen-2-ylcystinamide, Propanamide, 3,3′-dithiobis[2-amino-N-2-naphthalenyl-, (2R,2′R)-, Propanamide, 3,3′-dithiobis[2-amino-N-2-naphthalenyl-, [R-(R*,R*)]-, Propionamide, 3,3′-dithiobis[2-amino-N-2-naphthyl-, <span class="text-smallcaps">L</span>-
• CAS: 1259-69-4

Description

L-Cystine-DI-beta-naphthylamide (L-CDN) is a drug that is used to prevent preterm labor. It is a synthetic amino acid that has been shown to be effective in preventing premature birth in women with high levels of human chorionic gonadotropin (hCG). L-CDN inhibits the activity of aminopeptidase, which is an enzyme involved in the hydrolysis of proteins into their constituent amino acids. L-CDN binds to the active site of aminopeptidases and prevents them from hydrolyzing proteins. This prevents the breakdown of hCG, which is needed for pregnancy. L-CDN has been shown to be safe for use in animals, but more research needs to be done on its safety for humans.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 490.64 g/mol
• Formule: C₂₆H₂₆N₄O₂S₂
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder